...
首页> 外文期刊>Journal of Stem Cells and Regenerative Medicine >Cord blood-derived stem cells administered intravenously to newborn rats can engraft in brain and skin lesions and produce neuronal or epithelial progenitor cells
【24h】

Cord blood-derived stem cells administered intravenously to newborn rats can engraft in brain and skin lesions and produce neuronal or epithelial progenitor cells

机译:新生大鼠静脉内注射脐带血干细胞可植入脑和皮肤病变,并产生神经元或上皮祖细胞

获取原文
   

获取外文期刊封面封底 >>

       

摘要

CD133(+) cells isolated from umbilical cord blood (UCB) represent an established source of transplantable hematopoietic progenitors, and subpopulations of such cells have been shown to be capable of differentiating into mesenchymal lineages. Here we investigated whether CD133(+) UCB cells may contribute to the regeneration of injured brain and skin regions. A purified population of CD133(+) cells from human UCB was expanded in a stem cell medium, labeled with a fluorescent cell tracker and administered intravenously to 9-day-old rats subjected to unilateral carotid artery ligation and subsequent hypoxia (8% O2) for 120 minutes on day 7 after birth. The capability of these cells to differentiate into the neurogenic lineage was confirmed in vitro by RT-PCR and immunostaining of differentiation markers including NeuN and MAP2B. Their biodistribution in vivo was investigated by fluorescence microscopy and immunostaining of human nuclear antigen. Cell differentiation in vivo was assessed histologically and immunohistochemically using various markers. Animals which received a cell-free buffer and sham-operated animals treated with the stem cells served as controls. In caspase-3-positive brain lesions of all rats subjected to hypoxic-ischemic injury, numerous labeled cells were detected that expressed human nuclear antigen and CXCR4. Overlapping staining of NeuN and MAP2B revealed neurogenic differentiation of the transplanted cells. Furthermore, in the wounded jugular skin of all rats subjected to hypoxic-ischemic brain damage or sham-operation abundant human cells were detectable at the site of injury. Human cells located around the epidermal basement membrane and hair follicle bulges were positive for CD133 and epidermal differentiation markers, whereas CD133(-) human cells were found in the dermal connective tissue. Thus, UCB-derived stem cells can be mobilized from blood vessels into brain and skin lesions, where they may contribute to tissue regeneration.
机译:从脐带血(UCB)分离出的CD133(+)细胞代表了可移植造血祖细胞的既定来源,这种细胞的亚群已显示出能够分化为间充质谱系。在这里,我们调查了CD133(+)UCB细胞是否可能有助于受伤的大脑和皮肤区域的再生。从人UCB纯化的CD133(+)细胞群体在干细胞培养基中扩增,用荧光细胞追踪剂标记,并向接受单侧颈动脉结扎和随后的缺氧(8%O2)的9日龄大鼠静脉内给药出生后第7天120分钟。通过RT-PCR和包括NeuN和MAP2B在内的分化标志物的免疫染色,在体外证实了这些细胞分化为神经源性谱系的能力。通过荧光显微镜和人类核抗原的免疫染色研究了它们在体内的生物分布。使用各种标记在组织学和免疫组织化学上评估体内细胞分化。接受无细胞缓冲液的动物和用干细胞处理的假手术动物作为对照。在所有缺氧缺血性损伤大鼠的caspase-3阳性脑损伤中,检测到许多标记的细胞表达人核抗原和CXCR4。 NeuN和MAP2B的重叠染色揭示了移植细胞的神经源性分化。此外,在所有遭受缺氧缺血性脑损伤或假手术的大鼠的受伤颈静脉皮肤中,在损伤部位可检测到丰富的人细胞。位于表皮基底膜和毛囊隆起周围的人类细胞对CD133和表皮分化标记呈阳性,而在皮肤结缔组织中发现CD133(-)人类细胞。因此,源自UCB的干细胞可从血管动员到脑部和皮肤病变中,从而促进组织再生。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号